William Blair Initiates a Hold Rating on Terns Pharmaceuticals (TERN)
Terns Pharmaceuticals (TERN – Research Report) received a Hold rating and price target from William Blair analyst Andy Hsieh today. The ...
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer
Seasoned public company CFO with 25 years of leadership experience in biotechFOSTER CITY, Calif., Feb. 24, 2025 (GLOBE ...
Fintel on MSN5d
William Blair Initiates Coverage of Terns Pharmaceuticals (TERN) with Market Perform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of Terns Pharmaceuticals (NasdaqGS:TERN) with a ...
Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing ...
Terns Pharmaceuticals initiated with a Market Perform at William Blair
William Blair initiated coverage of Terns Pharmaceuticals (TERN) with a Market Perform rating.Discover the Best Stocks and Maximize Your ...
William Blair Initiates Coverage on Terns Pharmaceuticals (NASDAQ:TERN)
Equities researchers at William Blair started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) in a research note issued to investors on Friday, Marketbeat reports. The firm ...
TipRanks on MSN9d
Terns Pharmaceuticals Appoints Andrew Gengos as CFO
Terns Pharmaceuticals ( ($TERN) ) has issued an announcement. On February 22, 2025, Terns Pharmaceuticals announced the appointment of Andrew ...
ETF Daily News3d
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $18.30 Consensus Price Target from Brokerages
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has received an average rating of “Moderate Buy” from the six brokerages that are currently covering the firm, Marketbeat.com reports.
Morningstar9d
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer
FOSTER CITY, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage ...
Morningstar13d
Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors
FOSTER CITY, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage ...
Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer
Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule ...
C&EN11h
Good old pills vie for weight-loss market
The commercial success of the injectable peptide-based weight-loss drugs marketed by Novo Nordisk and Eli Lilly and Company ...